Arena Pharmaceuticals Inc
F:RN3N
Dividends
Dividend Yield
Arena Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Arena Pharmaceuticals Inc
Payout Ratio
Arena Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for RN3N is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RN3N Price
Arena Pharmaceuticals Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -43% |
| Market Capitalization | 5.6B EUR |
| Shares Outstanding | 61 564 100 |
| Percentage of Shares Shorted |
N/A
|
RN3N Return Decomposition
Main factors of price return
Stock Splits
RN3N's latest stock split occurred on Jun 19, 2017
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, RN3N traded at 1.117 per share. Afterward, the share price was about 13.36.
The adjusted shares began trading on Jun 19, 2017. This was the only stock split in RN3N's history.
